Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scheduling of GnRH antagonist IVF-ICSI cycles with luteal phase estrogen or combined oral contraceptives
2014-001809-40Phase 3Active
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of estradiol valerate, ethinylestradiol + levonorgestrel, avatrombopag and ethinyl estradiol in female infertility (3 arms), sponsored by Hospital La Paz Institute for Health Research. Primary endpoints: Pregnancy rate per cycle, Clinical pregnancy rate per cycle and 2 more. Started Jun 2015; status: active.
02
Drugs
estradiol valerateethinylestradiol + levonorgestrelavatrombopagethinyl estradiol
03
Conditions
female infertility
Beyond the preview
Go deeper on 2014-001809-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001809-40.